Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes
- PMID: 38690470
- PMCID: PMC11059148
- DOI: 10.7759/cureus.57288
Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes
Abstract
The global repercussions of coronavirus disease 2019 (COVID-19) include substantial worldwide mortality and have brought to light existing gaps in healthcare systems. Particularly, diseases requiring time-sensitive treatment, such as ST-elevation myocardial infarction (STEMI), have faced significant challenges due to the impact and revelations of the COVID-19 pandemic on healthcare infrastructure. This review addresses the impact of the pandemic on STEMI, exploring incidence, treatment modalities, and clinical outcomes. Through a critical examination of existing literature, the intricate relationship between the pandemic and cardiovascular health, specifically STEMI, is elucidated. The COVID-19 pandemic has had a significant impact on the management of STEMI, with changes in hospitalization rates, treatment strategies, and the presentation of the disease posing significant challenges. The contradictory results of COVID-19 and post-vaccine myocardial infarction, as well as gender differences in reported cases, highlight the need for further research to clarify these relationships.
Keywords: acute coronary syndrome; covid-19; covid-19 vaccination; myocardial infarction; st-elevation myocardial infarction (stemi).
Copyright © 2024, Choi et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.J Am Heart Assoc. 2022 May 3;11(9):e024451. doi: 10.1161/JAHA.121.024451. Epub 2022 Apr 26. J Am Heart Assoc. 2022. PMID: 35470683 Free PMC article.
-
Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.JAMA Cardiol. 2020 Dec 1;5(12):1419-1424. doi: 10.1001/jamacardio.2020.3629. JAMA Cardiol. 2020. PMID: 32766756 Free PMC article.
-
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14. Circ Cardiovasc Interv. 2020. PMID: 32791953
-
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19.Heart Fail Clin. 2023 Apr;19(2):197-204. doi: 10.1016/j.hfc.2022.08.007. Heart Fail Clin. 2023. PMID: 36863811 Free PMC article. Review.
-
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19.Cardiol Clin. 2022 Aug;40(3):321-328. doi: 10.1016/j.ccl.2022.03.007. Epub 2022 Mar 29. Cardiol Clin. 2022. PMID: 35851455 Free PMC article. Review.
Cited by
-
Incident prescriptions for common cardiovascular medications: comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems.BMC Cardiovasc Disord. 2025 Feb 5;25(1):82. doi: 10.1186/s12872-025-04492-3. BMC Cardiovasc Disord. 2025. PMID: 39910396 Free PMC article.
References
-
- Akbar H, Foth C, Kahloon RA, Mountfort S. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2023. Acute ST-elevation myocardial infarction. - PubMed
Publication types
LinkOut - more resources
Full Text Sources